TITLE:
Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

CONDITION:
Cerebral Stroke

INTERVENTION:
NXY-059

SUMMARY:

      This study will determine if NXY-059 will improve recovery from an acute stroke. The study
      is designed to look at both overall recovery and recovery of motor function, for example
      muscle strengthen and coordination.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Males and females

          -  Acute ischemic stroke with limb weakness

          -  Onset of symptoms within 6 hours

          -  Full functional independence prior to the present stroke

        Exclusion Criteria:

          -  Unconsciousness

          -  Subjects who are unlikely to complete the infusion of investigational product and/or
             are unlikely to undergo active medical management during that period due to a severe
             clinical condition.

          -  Severe illness with life expectancy less than 6 months.

          -  Known severe kidney disorder.

          -  Current known alcohol or illicit drug abuse or dependence.

          -  Pregnant or breast-feeding.

          -  Treatment with acetazolamide and methotrexate is not permitted during the infusion

          -  Participation in a previous clinical study within 30 days.

          -  Meets all other exclusion criteria.
      
